MDR extends Walmart deal

AUSTRALIAN medication management platform, MedAdvisor (MDR) has announced its US subsidiary, Adheris, has executed an enhanced agreement with pharmacy chain, Walmart.

Under the new deal, MDR will provide its full suite of medication adherence solutions to Walmart customers, across digital, in-store and direct mail platforms, while the pharmacy group will participate in “dynamic engagement” adding further scale to the MDR US network.

MDR CEO, Robert Read, said “Through our collaboration with Walmart, we are excited to expand our opportunity to help patients become more adherent and, as a result, have better health outcomes.”